136 related articles for article (PubMed ID: 36930693)
1. A PILOT STUDY OF ANGIOTENSIN II AS PRIMARY VASOPRESSOR IN CRITICALLY ILL ADULTS WITH VASODILATORY HYPOTENSION: THE ARAMIS STUDY.
See EJ; Clapham C; Liu J; Khasin M; Liskaser G; Chan JW; Serpa Neto A; Costa Pinto R; Bellomo R
Shock; 2023 May; 59(5):691-696. PubMed ID: 36930693
[TBL] [Abstract][Full Text] [Related]
2. Reduced exposure to vasopressors through permissive hypotension to reduce mortality in critically ill people aged 65 and over: the 65 RCT.
Mouncey PR; Richards-Belle A; Thomas K; Harrison DA; Sadique MZ; Grieve RD; Camsooksai J; Darnell R; Gordon AC; Henry D; Hudson N; Mason AJ; Saull M; Whitman C; Young JD; Lamontagne F; Rowan KM;
Health Technol Assess; 2021 Feb; 25(14):1-90. PubMed ID: 33648623
[TBL] [Abstract][Full Text] [Related]
3. VASOPRESSOR-RESISTANT HYPOTENSION, COMBINATION VASOPRESSOR THERAPY, AND SHOCK PHENOTYPES IN CRITICALLY ILL ADULTS WITH VASODILATORY SHOCK.
Priyanka P; Chang CH; Chawla LS; Kellum JA; Clermont G; Murugan R
Shock; 2022 Oct; 58(4):260-268. PubMed ID: 36018286
[TBL] [Abstract][Full Text] [Related]
4. Vasopressor therapy in critically ill patients with shock.
Russell JA
Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
[TBL] [Abstract][Full Text] [Related]
5. Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial.
Lamontagne F; Richards-Belle A; Thomas K; Harrison DA; Sadique MZ; Grieve RD; Camsooksai J; Darnell R; Gordon AC; Henry D; Hudson N; Mason AJ; Saull M; Whitman C; Young JD; Rowan KM; Mouncey PR;
JAMA; 2020 Mar; 323(10):938-949. PubMed ID: 32049269
[TBL] [Abstract][Full Text] [Related]
6. Exploring the norepinephrine to angiotensin II conversion ratio in patients with vasodilatory hypotension: A post-hoc analysis of the ARAMIS trial.
See EJ; Chaba A; Spano S; Maeda A; Clapham C; Liu J; Khasin M; Liskaser G; Eastwood G; Bellomo R
J Crit Care; 2024 Feb; 79():154453. PubMed ID: 37890357
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II and Vasopressin for Vasodilatory Shock: A Critical Appraisal of Catecholamine-Sparing Strategies.
Heavner MS; McCurdy MT; Mazzeffi MA; Galvagno SM; Tanaka KA; Chow JH
J Intensive Care Med; 2021 Jun; 36(6):635-645. PubMed ID: 32223515
[TBL] [Abstract][Full Text] [Related]
8. Vasopressor Therapy in the Intensive Care Unit.
Russell JA; Gordon AC; Williams MD; Boyd JH; Walley KR; Kissoon N
Semin Respir Crit Care Med; 2021 Feb; 42(1):59-77. PubMed ID: 32820475
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II in liver transplantation (AngLT-1): protocol of a randomised, double-blind, placebo-controlled trial.
Bokoch MP; Tran AT; Brinson EL; Marcus SG; Reddy M; Sun E; Roll GR; Pardo M; Fields S; Adelmann D; Kothari RP; Legrand M
BMJ Open; 2023 Nov; 13(11):e078713. PubMed ID: 37984940
[TBL] [Abstract][Full Text] [Related]
10. Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial.
Wieruszewski PM; Bellomo R; Busse LW; Ham KR; Zarbock A; Khanna AK; Deane AM; Ostermann M; Wunderink RG; Boldt DW; Kroll S; Greenfeld CR; Hodges T; Chow JH;
Crit Care; 2023 May; 27(1):175. PubMed ID: 37147690
[TBL] [Abstract][Full Text] [Related]
11. The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock.
Teixeira JP; Perez Ingles D; Barton JB; Dean JT; Garcia P; Kunkel SJ; Sarangarm P; Weiss NK; Schaich CL; Busse LW; Nielsen ND
Trials; 2024 Mar; 25(1):182. PubMed ID: 38475822
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II for the Treatment of Vasodilatory Shock.
Khanna A; English SW; Wang XS; Ham K; Tumlin J; Szerlip H; Busse LW; Altaweel L; Albertson TE; Mackey C; McCurdy MT; Boldt DW; Chock S; Young PJ; Krell K; Wunderink RG; Ostermann M; Murugan R; Gong MN; Panwar R; Hästbacka J; Favory R; Venkatesh B; Thompson BT; Bellomo R; Jensen J; Kroll S; Chawla LS; Tidmarsh GF; Deane AM;
N Engl J Med; 2017 Aug; 377(5):419-430. PubMed ID: 28528561
[TBL] [Abstract][Full Text] [Related]
13. Relative Hypotension and Adverse Kidney-related Outcomes among Critically Ill Patients with Shock. A Multicenter, Prospective Cohort Study.
Panwar R; Tarvade S; Lanyon N; Saxena M; Bush D; Hardie M; Attia J; Bellomo R; Van Haren F;
Am J Respir Crit Care Med; 2020 Nov; 202(10):1407-1418. PubMed ID: 32614244
[No Abstract] [Full Text] [Related]
14. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic Agents for the Treatment of Vasodilatory Shock.
Knotzer H; Poidinger B; Kleinsasser A
Curr Pharm Des; 2019; 25(19):2133-2139. PubMed ID: 31272348
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyethyl starch for fluid resuscitation in critically ill patients.
Bagshaw SM; Chawla LS
Can J Anaesth; 2013 Jul; 60(7):709-13. PubMed ID: 23604905
[TBL] [Abstract][Full Text] [Related]
17. Pharmacoepidemiology of metaraminol in critically ill patients with shock in a tertiary care hospital.
Sardaneh AA; Penm J; Oliver M; Gattas D; McLachlan AJ; Patanwala AE
Aust Crit Care; 2021 Nov; 34(6):573-579. PubMed ID: 33663948
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II for Vasodilatory Hypotension in Patients Requiring Mechanical Circulatory Support.
Wieruszewski PM; Seelhammer TG; Barreto EF; Busse LW; Chow JH; Davison DL; Gaglani B; Khanna AK; Ten Lohuis CC; Mara KC; Wittwer ED
J Intensive Care Med; 2023 May; 38(5):464-471. PubMed ID: 36524274
[No Abstract] [Full Text] [Related]
19. Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial).
Anstey MH; Wibrow B; Thevathasan T; Roberts B; Chhangani K; Ng PY; Levine A; DiBiasio A; Sarge T; Eikermann M
BMC Anesthesiol; 2017 Mar; 17(1):47. PubMed ID: 28327122
[TBL] [Abstract][Full Text] [Related]
20. Effects of propofol on vasopressor use in patients with sepsis and severe sepsis: A pilot study.
Marler J; Mohrien K; Kimmons LA; Vandigo JE; Oliphant CS; Boucher AN; Jones GM
J Crit Care; 2016 Oct; 35():155-60. PubMed ID: 27481752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
